Article R2131-1 of the French Public Health Code
I.- The medical biology or imaging tests used to assess the risk that the embryo or foetus has a condition likely to affect the progress or monitoring of the pregnancy, mentioned in II of article L. 2131-1 include : 1° Biochemistry tests on maternal serum markers ; 2° Obstetric and foetal ultrasound within the meaning of 1° of III of this article; 3° Genetic tests on free foetal DNA circulating…